MedCity News April 14, 2024
Frank Vinluan

Pharmaceutical companies use Feel Therapeutics’ technology to monitor the mental state of participants in clinical trials of behavioral medications. But the startup envisions its technology eventually also finding a place as a part of clinical care.

When it comes to evaluating the health of a patient, each therapeutic area has its own data-gathering tools. Think glucose monitors in diabetes and heart monitors for cardiovascular disease. But in mental health, a clinician relies on what a patient says. Self-reporting is incomplete and lacks objectivity, says George Eleftheriou, CEO and co-founder of Feel Therapeutics.

Feel is trying to bring more complete and objective data collection to the field of mental health. The San Francisco-based startup does it with wearable technology that continuously...

Today's Sponsors


Today's Sponsor


Topics: Biotechnology, Clinical Trials, Digital Health, Mental Health, Pharma, Pharma / Biotech, Provider, Technology, Trends, Wearables
Biosensor technology company Allez Health secures $60M
Dexcom report finds that living with Type 2 diabetes leads to anxiety, depression at 'alarming' rates
FDA seeks AI tech to predict, detect Parkinson’s symptoms
WearLinq Acquires AMI Cardiac Monitoring, Raises $6.7M for FDA-Cleared 6-Lead ECG Device
Your earbuds and you: What all that listening is doing to us : Body Electric

Share This Article